Kenya will not acquire the pfizer and moderna covid 19 vaccines, which are already available in the market. Instead the country will wait for the astrazeneca vaccine that is being produced in conjunction with oxford university. The ministry of health says clinical trials have been conducted in the country and that its efficacy is recommendable. The vaccine is set to be made available free of charge for kenyans, and the government